• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CU6 0.12% $8.70

CLARITY PHARMACEUTICALS LTD

Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical... Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. It is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. It has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CU6
CU6 - Media and Industry News
8 9 10
09:00 568 232K
09:00 Last post  ttppxx Comments Created with Sketch.  568  Views Created with Sketch.  232K 
CU6
Cu6 logistics
26/09/24 4 1.5K
26/09/24 Last post  ttppxx Comments Created with Sketch.  4  Views Created with Sketch.  1.5K 
CU6
CU6 - ASX Charts
14 15 16
26/09/24 958 339K
26/09/24 Last post  LuluC Comments Created with Sketch.  958  Views Created with Sketch.  339K 
CU6 26/09/24 0 397
26/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  397 
CU6 24/09/24 3 1.6K
24/09/24 Last post  Hingdog Comments Created with Sketch.  3  Views Created with Sketch.  1.6K 
CU6 23/09/24 1 743
23/09/24 Last post  Coit Comments Created with Sketch.  1  Views Created with Sketch.  743 
CU6
CU6 - General discussion
7 8 9
23/09/24 483 174K
23/09/24 Last post  Aqua65 Comments Created with Sketch.  483  Views Created with Sketch.  174K 
CU6
Share Price Before Buy Out
22/09/24 4 2.6K
22/09/24 Last post  royalgnomad Comments Created with Sketch.  4  Views Created with Sketch.  2.6K 

See All Discussions arrow Created with Sketch.

Timeline

Ceasing to be a substantial holder
26 Sep 08:17
 
Notification regarding unquoted securities - CU6
24 Sep 10:07
 
Date of Annual General Meeting
23 Sep 16:30
 
Initial Director's Interest Notice - Parker
20 Sep 14:48
 
Appointment of Executive Director to Clarity's Board
20 Sep 09:22
 
Becoming a substantial holder
20 Sep 08:19
 
View More arrow Created with Sketch.
(20min delay)
Last
$8.70
Change
0.010(0.12%)
Mkt cap ! $2.749B
Open High Low Value Volume
$8.82 $8.92 $8.57 $14.92M 1.715M

Buyers (Bids)

No. Vol. Price($)
2 1665 $8.57
 

Sellers (Offers)

Price($) Vol. No.
$8.72 7454 1
View Market Depth
Last trade - 16.10pm 26/09/2024 (20 minute delay) ?
Last
$8.58
  Change
0.010 ( 0.52 %)
Open High Low Volume
$8.83 $8.92 $8.57 168620
Last updated 15.59pm 26/09/2024 ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.